首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer cell international

缩写:CANCER CELL INT

ISSN:N/A

e-ISSN:1475-2867

IF/分区:7.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引4810条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Weishen Wang,Yi Zhao,Songyao Jiang et al. Weishen Wang et al.
Background: Aberrant liquid-liquid phase separation (LLPS) can alter biomolecular condensate functions and may influence pancreatic tumorigenesis and progression, but the specific role of LLPS regulators in prognosis and ...
Youxin Liu,Saipeng Chen,Jie Xu et al. Youxin Liu et al.
Background: The tumor microenvironment (TME), especially tumor-associated macrophages (TAMs), plays a critical role in prostate cancer (PCa) progression. Cathepsin Z (CTSZ) is a lysosomal protease implicated in various ma...
Ke Yang,Guixin Zhu,Yanyan Li et al. Ke Yang et al.
Background: Head and neck squamous cell carcinoma (HNSCC), the seventh most common cancer worldwide, is strongly associated with chronic inflammation. While chronic inflammation is often localized, systemic inflammation r...
Wei Wang,Lijiang Zhou,Jing Wang et al. Wei Wang et al.
Background: Cisplatin is a widely used chemotherapy drug, but resistance mechanisms, including the role of SLFN11, pose significant challenges in colorectal cancer (CRC) treatment, with only 15-20% of patients showing obj...
Muli Wudu,Haijun Lou,Yuyu Ma et al. Muli Wudu et al.
Lung adenocarcinoma is a common type of lung cancer with high incidence and mortality rates. TMEM33, a tumor-associated protein, has not been fully elucidated in lung adenocarcinoma. To explore the expression of TMEM33 in lung adenocarcinom...
Yiwen Ma,Shisheng Wang,Xiaorui Li et al. Yiwen Ma et al.
Approximately 15% to 20% of patients with breast cancer are human epidermal growth factor 2 (HER2)-positive, and this type has a high recurrence rate. With the application of anti-HER2 drugs such as trastuzumab, the prognosis of patients wi...
Hooriehsadat Amini,Negin Ebrahimi,Sayedali Mousavirahimi et al. Hooriehsadat Amini et al.
The BRAFV600E mutation is a key oncogenic driver in multiple cancers. While FDA-approved BRAF inhibitors exist, their efficacy is often limited by drug resistance and adverse effects, necessitating the discovery of novel therapeutic agents....
Taraneh Rezaei,Mobina Abidi,Yaser Mohammadi et al. Taraneh Rezaei et al.
Background: Higher prevalence of hepatocellular carcinoma (HCC) in men is largely attributed to the sex hormones and behavioral risk factors. This study investigated the effects of male (testosterone) and female (estradio...
Jing Chen,Li-Xin Ren,Yong Ma et al. Jing Chen et al.
Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide because of metastasis. The class II α-isoform of phosphatidylinositol 3-kinase (PIK3C2A) was found to be a regulator in proliferation and migration of endothelial c...
Rong-de Zhong,Qian Li,Heng Wang et al. Rong-de Zhong et al.
Objective: To investigate MRI-based radiomic features in glioma and key genes related to IDH mutations, and to analyze their correlation. Methods: ...